Placebo | 3 mg/kg q 8 wks | 3 mg/kg q 4 wks | 10 mg/kg q 8 wks | 10 mg/kg q 4 wks | Total infliximab | |
---|---|---|---|---|---|---|
Number of ACR 20 | 63 | 39 | 42 | 41 | 32 | 154 |
ACR-N at Week 30 | 1.2 | 2.3 | 2.9 | 3.5* | 3.3* | 3.0* |
ACR-N at Week 54 | 2.4 | 9.4* | 9.0* | 17.1* | 17.8* | 13.1* |
ACR-N at Week 102 | 3.3 | 12.2* | 6.7 | 18.7* | 10.1* | 11.9* |
Change in TSS at Week 30 | 5.1 | 2.3 | 0.8* | <0.1* | 0.5* | 0.9* |
Change in TSS at Week 54 | 7.2 | 3.0* | 1.9* | 0.2* | 0.3* | 1.3* |
Change in TSS at Week 102 | 13.5 | 3.7 | 1.8* | 0.9* | -0.8* | 1.4* |
*p < 0.05.